Compound Taxus chinensis Capsule Combined with Chemotherapy for Non-Small-Cell Lung Cancer: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Compound Taxus chinensis capsule (CTCC), an antitumor Chinese patent medicine, has been commonly prescribed as an adjunctive agent to chemotherapy for the management of non-small-cell lung cancer (NSCLC); however, the effects of CTCC added to chemotherapy for NSCLC patients have never be...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Keshuai, Cheng, Haibo, Shen, Weixing, Leung, Elaine Lai-Han, Le, Shao, Yu, Lili, Xie, Han, Sui, Xinbing, Zhu, Xiaoming, Wu, Qibiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702306/
https://www.ncbi.nlm.nih.gov/pubmed/34956388
http://dx.doi.org/10.1155/2021/9535061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702306/
https://www.ncbi.nlm.nih.gov/pubmed/34956388
http://dx.doi.org/10.1155/2021/9535061

Ejemplares similares